• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Journal of leukocyte biology

    Journal of leukocyte biology

    JournalISSN 0741-5400eISSN 1938-3673中科院 医学 4区

    年发文量

    研究主题

    论文(14743)

    排序
    1Parental Obesity is Associated with Altered Hematopoiesis and Impaired Viral Immunity in Offspring
    Emily C Allene, Sabareesh P Sundarraj, Zahra Alibolandi,Niloufar Khojandi, Eric Piening,Alexander Piening, Maisie Pritchett,Laurie P Shornick,Ryan M Teague

    Abstract The prevalence of obesity among adults of childbearing age has tripled worldwide since 1975. Obesity during pregnancy has been linked to impaired neonatal immunity and a higher risk of infections in childhood but the causal mechanisms have not been defined. Using a mouse model of diet-induced obesity, we documented impaired antiviral immunity in the offspring of obese mice, corresponding with reduced cell-mediated immune responses. This included lower frequencies of Tbet+ CD4+ T helper 1 cells and a decrease in cytotoxic CD8+ T cells in the lungs of mice infected with respiratory Sendai virus, and confirmed in spleens from mice infected with LCMV. Consistent with impaired cellular immunity, single-cell transcriptomic analysis of bone marrow revealed altered hematopoiesis in these offspring, with evidence of interferon-induced skewing toward myelopoiesis at the expense of lymphocyte development. Our studies provide an in-depth transcriptomic profile of immune cell progenitors in the bone marrow paired with mature innate and adaptive immune cell populations in lymph nodes at single-cell resolution. Results suggest that compromised immune protection from viral infections in the offspring of obese mice stems from altered lymphocyte development that is influenced by inflammatory interferon signaling in bone marrow.

    2026
    引用
    AI阅读
    加入学术空间
    2IL-15/IL-15Rα-targeted CRISPRa Boosts NK Cell Effector Function Against HIV-infected Cells
    Samuel Brancazio,Tricia H Burdo,Liang Shan,Rafal Kaminski

    Abstract Like many other immune cell types, natural killer (NK) cells exhibit impaired functionality in people with HIV (PWH), limiting their ability to efficiently target and eliminate HIV-infected cells and contributing to the persistence of the HIV reservoir. Recently, adoptive NK cell therapy using activated or engineered NK cells has emerged as a promising immunotherapeutic strategy for cancer; however, its application to HIV remains in the early stages of development. NK cells primarily rely on interleukin-15 (IL-15) signaling for their development, survival, and maintenance, and dysregulated IL-15 signaling has been reported in PWH. We hypothesized that simultaneous enhancement of IL-15 and IL-15 receptor alpha (IL-15Rα) expression would improve NK cell effector function and promote clearance of HIV reservoir. Utilizing dCas9-VPR-mediated multiplex CRISPR activation (CRISPRa), we successfully upregulated both IL-15 and IL-15Rα expression in the same primary NK cells without altering the genomic sequence. CRISPRa-treated NK cells displayed increased IL-15 and IL-15Rα transcript levels, as measured by RT-qPCR and significantly elevated surface expression of IL-15Rα, as determined by flow cytometry. Enhanced IL-15/IL-15Rα expression increased NK cell metabolic activity and cytotoxicity against target K562 cells, a chronic myelogenous leukemia cell line, indicating improved effector function. Furthermore, in co-culture experiments using an HIV-positive T-cell line, IL-15/IL-15Rα-CRISPRa-treated NK cells demonstrated enhanced target cell elimination and increased secretion of IFN-γ. Together, these findings provide a proof of concept that multiplex CRISPRa can be used to enhance NK cell function, representing a novel strategy to improve persistence and therapeutic efficacy in HIV and other disease settings.

    2026
    引用
    AI阅读
    加入学术空间
    3Bile Acid-Activated IRE1α Pathway Promotes NK Cell-Mediated Cholangiocyte Injury in Primary Sclerosing Cholangitis.
    Chenglu He, Ying Zhao, Jing Chen, Yu Song, Min Zhong,Hongqiong Shi, Ya Li, Bin Shan

    Abstract Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by progressive bile duct inflammation and fibrosis. Despite its significant clinical burden, the molecular mechanisms underlying PSC, pathogenesis remain poorly understood, limiting therapeutic options. Here, we integrated bioinformatic analyses of transcriptomic datasets with experimental validation in a bile duct ligation mouse model and in vitro cell systems. Differential gene expression, weighted gene co-expression network analysis, and Mendelian randomization were performed to identify key molecular signatures. Single-cell RNA sequencing characterized cellular heterogeneity. The IRE1α-NK cell axis was validated using pharmacological inhibition, siRNA knockdown, and NK cell depletion approaches in bile acid-treated NK cells, co-culture systems, and a mouse model of cholestatic bile duct injury. We identified Endoplasmic Reticulum To Nucleus Signaling 1 (ERN1) as a key mediator in PSC pathogenesis, with causal relationships to disease risk. Single-cell transcriptomic analysis revealed significant NK cell enrichment in PSC samples. In both the bile duct ligation mouse model and in vitro systems, bile acids induced IRE1α pathway activation in NK cells, leading to enhanced cytotoxicity against cholangiocytes. Pharmacological inhibition or genetic knockdown of IRE1α prevented bile acid-induced NK cell activation and cytotoxicity. In vivo, both IRE1α inhibition and NK cell depletion attenuated liver injury, inflammation, and fibrosis in the mouse model. Our data suggest a novel pathogenic mechanism in PSC involving bile acid-induced IRE1α activation in NK cells, promoting cholangiocyte injury. The IRE1α-NK cell axis represents a promising therapeutic target for PSC treatment.

    2026
    引用
    AI阅读
    加入学术空间
    4Large Peritoneal Macrophages Influence CD8+ T Cell Activation and Parasite Control During Acute Trypanosoma Cruzi Infection.
    R. E. Baigorri, M. E. Viano, Florencia Hellriegel, Camila Fontanari,Gastón Bergero, Yanina L. Mazzocco, Matías Vazquez-Vignale,María Belén Brugo, C. C. Motrán, M. Aoki, M. C. Rodriguez-Galán, C. Stempin,

    Resident peritoneal macrophages consist of two subpopulations with distinct origin, sizes and phenotype named Large Peritoneal Macrophages (LPMs) and Small Peritoneal Macrophages (SPMs). While LPMs are long-live cells that origin in embryonic yolk sac and can self-replenish after mild loss, SPMs are short-live cells that derive from blood monocytes and are in continuous replenishment. Under homeostasis, LPMs constitute more than 70% of total CD11b+ cells, but during infection or inflammation drastically dampen. As LPMs have been reported to be essential for CD8+ T cell priming and replication control in parasite infections, we aimed to study their role in the context of Chagas' disease. We observed a reduction in LPMs during acute phase of T. cruzi infection in BALB/c mice that did not restore in chronic phase. Instead, this subset was replaced by a population with intermediate expression of F4/80, previously described as 'inflammatory macrophages', but with a mixed phenotype activation in this case. Besides, this F4/80int population could also be associated with truncated maturation of monocytes to resident macrophages. In this work, LPMs showed higher CD80+ and lower PD-L1+ cells frequencies and produced more IL-12 and TNF than SPMs. This profile may favor CD8+ T-cell activation, reflected by increased CD69 expression and Perforin/Granzyme B production. Replenishment of LPMs by adoptive transfer of PEMs was associated with reduced parasitemia and enhanced splenic CD8+ T-cell activation. Thus, LPMs may contribute to CD8+ T-cell responses and parasite control during acute T. cruzi infection.

    2026
    引用
    AI阅读
    加入学术空间
    5SOX2/TSTA3 Suppresses CD8+ T-cell-mediated Immune Response in Breast Cancer by Regulating Programmed Death Ligand-1 Fucosylation
    Jia Hong, Su Shao

    Abstract Immune escape in breast cancer is a primary contributor to immunotherapy resistance and poor patient prognosis. Fucosylation is essential for tumor progression, but the regulatory mechanism of its key enzyme, guanosine diphosphate-L-fucose synthase (TSTA3), within the breast cancer immune microenvironment remains unexplored. This study combined bioinformatics and experimental approaches to investigate TSTA3 in breast cancer. TSTA3 expression was validated by quantitative real-time reverse transcription polymerase chain reaction and western blotting. Functional assays in a tumor–T-cell coculture system showed that TSTA3 knockdown enhanced CD8+ T-cell cytotoxicity and suppressed tumor malignancy. Mechanistically, TSTA3 fucosylated programmed death ligand-1, and this modification was confirmed by Ulex europaeus agglutinin-1 chromatography and co-immunoprecipitation. SOX2 was identified as an upstream transcription factor of TSTA3 via chromatin immunoprecipitation and dual-luciferase assays. The SOX2/TSTA3/programmed death ligand-1 axis was functionally validated in rescue experiments and in vivo tumor models. TSTA3 was highly expressed in breast cancer tumors. Its knockdown enhanced CD8+ T-cell cytotoxicity and suppressed tumor proliferation, migration, and invasion in vitro. Mechanistically, TSTA3 upregulated programmed death ligand-1 expression in a fucose-dependent manner and, partly through programmed death ligand-1, suppressed CD8+ T-cell-mediated antitumor immune responses. SOX2 directly activated TSTA3 transcription, leading to programmed death ligand-1 stabilization via fucosylation. In vivo, targeting the SOX2/TSTA3/programmed death ligand-1 axis inhibited tumor growth and boosted CD8+ T-cell activity. Collectively, this study uncovered a novel mechanism whereby SOX2 transcriptionally activated TSTA3, which fucosylated programmed death ligand-1 and, partly through programmed death ligand-1, suppressed CD8+ T-cell-mediated antitumor immune responses, providing a theoretical basis for targeting the SOX2/TSTA3/programmed death ligand-1 axis to enhance immunotherapy in breast cancer.

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 14743 篇论文

    高被引作者

    作者引用发文
    Kevin J. Tracey781616
    Timothy Ravasi72828
    Kate Schroder69007
    Paul Hertzog68267
    Kouji Matsushima603736
    Alberto Mantovani579351
    Marco Bianchi536414
    David Mosser480225
    Laurence Zitvogel45646
    Caroline Flament45645

    高产作者

    作者引用发文
    Alberto Mantovani579351
    Elizabeth J. Kovacs194944
    Stefanie N. Vogel203644
    Debra L Laskin187644
    Helene F. Rosenberg113544
    Michael T. Lotze145841
    Timothy R. Billiar347639
    Claes Dahlgren131337
    Kouji Matsushima603736
    Siamon Gordon129635

    相关期刊

    Immunological Reviews
    Journal of Experimental Medicine
    Trends in Immunology
    Cellular & Molecular Immunology
    Annual Review of Immunology
    Nature Immunology
    Journal of Immunology
    European Journal Of Immunology
    Journal of Immunology Research
    Immunology Letters